Connect with us

International

Weekly Market Pulse: Signal To Noise Ratio

The stock market surged last Friday after the employment report showed a gain of over 300k jobs while the year over year change in average hourly earnings…

Published

on

The stock market surged last Friday after the employment report showed a gain of over 300k jobs while the year over year change in average hourly earnings fell to 4.3%. That was the popular explanation and it makes sense; continued economic growth and fading inflation pressures would certainly seem a big positive (although wages have little to do with the recent bout of rising prices). Regardless of the reason, the surge in stocks was, for once this year, across the board. 

Analyzing markets and the economy during and since the pandemic has been extraordinarily difficult and this year has brought no relief. It has been the narrowest of markets with just 7 large cap growth stocks accounting for all the gains in the S&P 500. An index of the other 493 stocks in the S&P 500 is down for the year.

These are all in the top 10 holdings of the S&P 500 and so have an outsized weight in the index. As a group they aren’t cheap at an average forward P/E of 41. Some of the individual names aren’t that outrageously expensive but as a group the multiple is hard to justify. Of course, with artificial intelligence, you can put any multiple you like on any company that has any tangential connection to it since no one has any idea yet what the impact of AI will be. And that is certainly the case with NVDA at 40 times sales, 200 times trailing earnings, 52 times forward estimates and 140 times cash flow. By those measures, META and GOOG, at 6 times sales and roughly 23 times expected earnings, seem positively reasonable. Growth in revenue and EPS are basically flat year over year but if you ignore that you can probably make a case for them.

But the gap in performance this year isn’t just about those 7 stocks. It is actually two dimensional with growth outperforming value and large company stocks outperforming small company stocks. The Russell 1000 (large cap) growth index has outperformed the Russell 1000 value index by 22.6% just since the beginning of the year. It has also outperformed the S&P 600 (small cap) growth index by 19.9%. 

Stocks were hit hard last year because of fears about inflation and higher interest rates. Higher rates, all else equal, mean lower valuations for stocks so it isn’t coincidence that stocks made their lows last year when interest rates made their highs (neither is it coincidence that stocks have been great things to own since interest rates peaked in the early 80s). Since the lows, value and growth performed about the same until May when the AI mania started to take hold. The gap between growth and value in May alone was 8.5%.

What this means, at least to me, is that the conversation around markets has shifted in the last two months from fears about inflation and interest rates to fears about economic growth – recession. Starting in April after the several bank failures, the market started to price in Fed rate cuts before the end of the year. At the peak of growth concerns, about  two weeks ago, the market put the highest probability on 3 rate cuts by December. In other words the Fed Funds market was, at least partially, pricing in an imminent recession. 

In the course of the last two weeks and especially late last week, those rate cuts were mostly priced out of the markets. As of Friday, the highest probability for the Fed funds rate in December was for 5-5.25%, exactly where it is today. These probabilities shift all the time so that could change soon, but for now, recession fears have faded considerably. 

The big news from Friday is that the rally wasn’t led by growth stocks. Value stocks and small company stocks led the way along with REITs. All of those are more economically sensitive than growth so the good news in the employment report Friday was sufficient to move them higher. The size of the move was probably driven more by positioning; large spec accounts have been short the S&P in size for several months and also short the Russell 2000 (small caps). 

So, what about the economic growth outlook? I have said before that investors’ emphasis on the employment report as a measure of economic growth is misplaced. The initial report for any given month is basically nothing more than an educated guess and educated is used loosely in that sentence. The monthly job totals are subject to such large revisions that even the sign (+ or -) is often revised. But last week’s report did show upward revisions to recent months which is of some comfort and some confirmation that the jobs market is still trending in a positive direction. (See below for some commentary on the difference between the household and establishment surveys.)

The global economy is still suffering from a post-COVID hangover, a mixture of a slowing goods economy (ISM manufacturing new orders 42.6) and a services economy still in recovery mode (most of the new jobs in Friday’s report were in service industries). The result is an economy growing at the long term trend of about 2%. The question is what happens next, a services slowdown or a manufacturing recovery or both at the same time? Or do services just join goods in an economywide slowdown, a recession? The latter would certainly be the more traditional and expected outcome but this economy hasn’t done anything traditional and expected in quite a while. It is next to impossible to predict the future course of the economy in the best of circumstances and COVID has made it harder still.

While we don’t know the future we can observe the present. With the economic outlook right now dependent on the path of goods and services consumption (which also affects investment) we can look at that in a variety of ways. Real goods consumption, contrary to the popular narrative, is not falling. Production, which is what the ISM and regional Fed surveys are about, is slowing but goods consumption, while down a little over 3% from the March 2021 peak, is unchanged over the last two years and is essentially, now, right on trend:

Real services consumption over the same two year period is up 7.4% but is still slightly below the pre-COVID trend.

Where do things go from here? I can’t predict the future but, again, we can make some observations about the present that might be helpful. Production has stalled because COVID and its supply chain issues produced an inventory glut that had to be worked off. Inventories reduced Q1 GDP growth by 2.1 percentage points but with total inventories nearly flat over the last six months (which means real inventories are down) that drag is likely set to ease and maybe reverse. That will, of course, depend, to some degree, on future consumption but with real disposable personal income up 3.4% over the last year (which is a tad over the long term annual average) and savings still well above the pre-COVID level, there is room for some optimism on consumption. 

The economy has its issues as it always does but the basics seem to be in good shape. If that remains true, there is reason to believe that value stocks and small cap stocks, which are more cyclical than large growth stocks, will recover some – or all and then some – of their relative performance deficit of this year.  

Environment

10 year Treasury yields were down some last week as the debt ceiling issue was resolved, but the economic data was generally confusing and somewhat contradictory. The Chicago PMI, the Dallas Fed manufacturing survey and the ISM manufacturing survey were weaker than expected with ISM new orders particularly weak. That also fed through to prices though which fell to 44.2 from 53.2, taking some pressure off on the inflation front.

On the other hand the JOLTs report saw a rise in job openings and the employment reports (ADP and official) were both pretty strong while average hourly earnings moderated some. Construction spending rose and is now up over 7% year over year. Case-Shiller reported a rise in house prices of 1.5%, much stronger than expected and an indication that house inflation, of all things, isn’t dead yet.

All of that added up to a slight fall in longer term Treasury yields, a flat 2 year and continued rise in the 3 month T-Bill rate. As expected the 1 month bill rate did fall some after the debt ceiling bill passed but the rate is still in an uptrend. The probability of a rate hike at the June FOMC meeting is now down to about 25% but the odds of hike in July have risen to a bit over a coin flip. Longer term the market has about a 40% chance that the Fed Funds rate is unchanged by the end of the year.

So, to recap, the 10 year and 2 year Treasury yields are in short term downtrends (which could just as easily be called neutral or no trend) while shorter term rates are in short term and intermediate term uptrends. Put all that together and what you get is…not much. The yield curve is still inverted (and has gotten more inverted recently) but there is little sign of recession right now. In other words, about the same as it has been for the last year.

The short term US dollar trend also remains neutral as the Fed last week seemed to indicate it would skip a hike at the June meeting while Lagarde said the ECB will persist. The economic data in Europe hasn’t been that bad outside of Germany but the accepted narrative is that the EU is weaker than the US. Inflation does seem to be coming down fairly rapidly though so Lagarde may just be talking tough.

Markets

The major asset classes were all higher last week with most – in some cases more than all – of the gains in risk assets coming on Friday. Previous laggards played some catch up Friday with REITs, small caps and value stocks all outperforming. Non-US stocks were also generally higher for the week with Latin America and Japan leading.

The outperformance of growth, and specifically large cap growth, this year has been extreme and we should expect to see some reversion to the trend. Small caps and real estate are particularly unloved right now and both did well in the Friday rally. Small cap value stocks were up over 4% on Friday alone and still have a long way to go just to get back to the previous downtrend. This set up is very similar to one we saw after the initial COVID selloff:

The correction in the value trade has been getting a lot of attention but the small/large divergence is more extreme. The value correction looks like exactly that to me – a correction.

The rally on Friday was nice but the S&P 500 is just back to its highs of last August and I think we can all agree that sentiment in large growth stocks is a bit frothy. The rally in REITs and small cap value may be more important because sentiment is already so poor. The gloom and doom around REITs and real estate more generally is palpable. It is unusual to see sentiment so deeply negative for an index that is actually up on the year but that is the situation. Some of the big office REITs are trying to bottom too with SL Green up over 9% last week while Vornado and Boston Properties were both up over 6%. There are still a lot of problems in the real estate space so this may just be the proverbial dead cat bounce but it bears watching for sure.

Cyclicals were the leaders last week as recession fears eased with the employment report Friday and the Fed’s loud whispers about skipping a rate hike next week. Laggards were the defensives and energy. Crude oil is holding above the March and May lows but is still in a downtrend. I don’t see a sufficient change in the supply/demand picture to make much difference either way but I suppose OPEC could change that. Will they? They are meeting as I type this so we’ll find out soon. The Saudi energy minister did warn last week that speculators should expect more pain like they felt after the surprise April production cut but that rally faded to a new low so I’m not sure that’s the boot shaking comment he thinks it is.

Economic/Market Indicators

The unemployment rate ticked higher last month to 3.7%, a result of the job losses reported in the household survey. Everyone who is bearish on the economy is pointing to the difference between the establishment survey job gains and the household survey job losses. (For those who don’t know, the reported monthly job gains/losses come from the establishment survey while the unemployment rate is calculated from the household survey. No, I have no idea why there are two surveys.) If it was the other way around everyone who is bullish would be pointing to the household survey. That’s called confirmation bias and we’re all guilty of it to some degree.

So, let’s put this to rest once and for all. Here’s a chart of the difference between the change in the household survey and the change in the establishment survey on a monthly basis. If you see any pattern here it’s because you want to. This is all noise and no signal. 

The advance in the S&P 500 this year has been very narrow with just a few stocks leading the market. There has been a lot of commentary about how negative this is, how it will all fall apart soon when investors finally wake up to reality and the AI stocks crash, but frankly there isn’t much evidence to support that. Bull markets, especially at the beginning, are often led by a small group of stocks before they broaden out and more stocks join the rally. I’m sure there are exceptions and someone will waste their time this week making sure I know all about them.

The rally isn’t really as narrow as it seems anyway. Yes, if you take out those 7 stocks the S&P 500 would be down but there are plenty of stocks that are up this year that aren’t tech or AI stocks. 125 stocks in the S&P 500 are up more than the average this year so it isn’t just 7 stocks. Cruise lines, industrials, homebuilders, restaurants, healthcare, materials, real estate and even financial service companies are all represented in those 125 stocks.

The divergence between growth and value so far this year is extreme but extreme is the new normal. All trends these days seem to get taken to an extreme, a function I think of the ready availability of information. All new data is incorporated into investors’ views, acted upon immediately and simultaneously. The result is that new information is overvalued, everything extrapolated to its extreme. Good news becomes great news; bad news becomes disastrous.

There is more information available today to the average investor than ever but the signal to noise ratio is the lowest ever too. More information is not the same thing as more useful information. The best investment an investor can make today is a good set of earplugs.

Joe Calhoun

 

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending